BRUKER CORPORATION

BRKR
Exchange NMS, Currency in USD
Loading price...

Overview

Previous Close64.31
Open54.07
Ask52.74
Bid50.20
Day's Range50.12 - 56.37
52 Week Range28.53 - 65.30
PE Ratio(TTM)--
Market Cap7.66B
Volume8.82M
Avg. Volume2.49M
12 Months Earnings-11.60M
12 Months Revenue3.46B

Performance

ABSCAGR
YTD1 Month3 Months1 Year2 Years5 Years10 Years
No results to display

Profit/Loss

PARTICULARSTTM20252025202420232022
Operating Revenue3.46B3.44B3.44B3.37B2.96B2.53B
Cost of Revenue1.89B1.86B1.78B1.72B1.45B1.23B
Gross Profit1.57B1.58B1.66B1.65B1.51B1.31B
Operating Expenses1.36B1.34B1.33B1.27B1.02B843.30M
Profit after Tax (Net Income)-11.60M-8.60M79.60M113.10M427.20M296.60M

Company Profile

Sector: Healthcare
Industry: Medical Devices
HQ Location: Billerica, United States
Website: https://www.bruker.com
Chairman, CEO & President: Dr. Frank H. Laukien Ph.D.
Employees: 11,085
About Company:
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
DISCLAIMER: Stock prices are not real time and the delay can range from a few seconds to several minutes. The data displayed are solely for informational purposes, not for trading purposes or advice.